Activation of G-protein-coupled receptors: A common molecular mechanism

Trends in Endocrinology and Metabolism

Volumn 14, Issue 9, 2003, Pages 431-437

  Karnik, Sadashiva S ^a   Gogonea, Camelia ^a   Patil, Supriya ^a   Saad, Yasser ^a   Takezako, Takanobu ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; RHODOPSIN;

AGONIST; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG DEVELOPMENT; GENETIC CONSERVATION; GENETICS; HUMAN; LIGAND BINDING; MODEL; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN MOTIF; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0242696218     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2003.09.007     Document Type: Review

References (60)

1. Baldwin, J.M. et al. (1997) An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J. Mol. Biol. 272, 144-164
2. Henderson, R. and Unwin, P.N.T. (1975) Three dimensional model of purple membrane obtained by electron microscopy. Nature 257, 28-32
3. Teller, D.C. et al. (2001) Advances in determination of a high-resolution three dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40, 7761-7772
4. Subramaniam, S. et al. (1999) Protein conformational changes in bacteriorhodopsin photocycle. J. Mol. Biol. 287, 145-161
5. Meng, E.C. and Bourne, H.R. (2001) Receptor activation: what does the rhodopsin structure tell us? Trends Pharmacol. Sci. 22, 587-593
6. Gether, U. (2000) Uncovering molecular mechanisms involved in activation of G protein coupled receptors. Endocr. Rev. 21, 90-113
7. Lander, E. et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-922
8. Kolakowski, L.F. Jr (1994) GCRDb: a G-protein-coupled receptor database. Receptors Channels 2, 1-7
9. Fredriksson, R. et al. (2003) The G-protein coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups and fingerprints. Mol. Pharmacol. 63, 1202-1205
10. Porter, J. et al. (1996) Activation of the α1β-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. J. Biol. Chem. 271, 28318-28323
11. 1 receptor. J. Biol. Chem. 274, 7103-7110
12. Ji, T.H. et al. (1998) G protein-coupled receptors. Diversity of receptor-ligand interactions. J. Biol. Chem. 273, 17299-17302
13. Farrens, D.L. et al. (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274, 768-770
14. Sheikh, S.P. et al. (1996) Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature 383, 347-350
15. Abdulaev, N.G. and Ridge, K.D. (1998) Light-induced exposure of the cytoplasmic end of transmembrane helix seven in rhodopsin. Proc. Natl. Acad. Sci. U. S. A. 95, 12854-12859
16. Miura, S. et al. (2003) TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor. J. Biol. Chem. 278, 3720-3725
17. 1 receptor alters the spatial proximity of transmembrane 7 to the ligand binding pocket. J. Biol. Chem. (in press)
18. Gether, U. et al. (1997) Agonists induce conformational changes in transmembrane domains III and VI of β2-adrenergic receptor. EMBO J. 16, 6737-6747
19. Ballesteros, J.A. et al. (2001) Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 29171-29177
20. Sheikh, S.P. et al. (1999) Similar structures and shared switch mechanisms of the β2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation. J. Biol. Chem. 274, 17033-17041
21. Chen, S. et al. (1999) Phe310 in transmembrane VI of the α1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding. J. Biol. Chem. 274, 16320-16330
22. Schultz, A. et al. (2000) Requirement of specific intrahelical interactions for stabilizing the inactive conformation of glycoprotein hormone receptors. J. Biol. Chem. 275, 37860-37869
23. Parnot, C. et al. (2002) Lessons from constitutively active G-protein-coupled receptors. Trends Endocrinol. Metab. 13, 336-343
24. 1 receptor is essential for full agonism. J. Biol. Chem. 270, 12846-12850
25. Blanpain, C. et al. (2003) The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J. Biol. Chem. 278, 5179-5187
26. Mills, J.S. et al. (1998) Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry. J. Biol. Chem. 273, 10428-10435
27. Davison, J.S. et al. (1997) Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment. Biochemistry 36, 12881-12889
28. Stroop, S.D. et al. (1996) Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions. Endocrinology 137, 4752-4756
29. Kuwasako, K. et al. (2003) The function of extracellular cysteines in the human adrenomedullin receptor. Hypertens. Res. 26, S25-S31
30. Dautzenberg, F.M. et al. (1999) The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptors reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile. J. Neurochem. 73, 821-829
31. Sydow, S. et al. (1999) The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding. Eur. J. Biochem. 259, 55-62
32. Nanevicz, T. et al. (1996) Thrombin receptor activating mutations. Alteration of an extracellular agonist recognition domain causes constitutive signaling. J. Biol. Chem. 271, 702-706
33. 2+ cascades. Mol. Endocrinol. 9, 725-733
34. Li, S. et al. (2001) Mutations of the second extracellular loop of the human lutropin receptor emphasize the importance of receptor activation and de-emphasize the importance of receptor phosphorylation in agonist-induced internalization. J. Biol. Chem. 276, 7968-7973
35. Chen, C.R. et al. (2003) Targeted restoration of cleavage in a noncleaving thyrotropin receptor demonstrates that cleavage is insufficient to enhance ligand-independent activity. Endocrinology 144, 1324-1330
36. Vlaeminck-Guillem, V. et al. (2002) Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol. Endocrinol. 16, 736-746
37. 2+-sensing function of the metabotropic glutamate receptors. Science 279, 1722-1725
38. Malherbe, P. et al. (2003) Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor. J. Biol. Chem. 278, 8340-8347
39. Litschig, S. et al. (1999) CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. Mol. Pharmacol. 55, 453-461
40. Bessis, A.S. et al. (2002) Closure of the Venus flytrap module of mGlu8 receptor and the activation process: insights from mutations converting antagonists into agonists. Proc. Natl. Acad. Sci. U. S. A. 99, 11097-11102
41. Malherbe, P. et al. (2001) Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor. Mol. Pharmacol. 60, 944-954
42. Chong, J.M. et al. (2002) Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules. J. Biol. Chem. 277, 5134-5144
43. Hamann, J. et al. (1998) Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Eur. J. Immunol. 28, 1701-1707
44. Seifert, R. et al. (1999) Effects of guanine, inosine and xanthine nucleotides on β2-adrenergic receptor/Gs interaction: evidence for multiple receptor conformations. Mol. Pharmacol. 56, 348-358
45. Karnik, S.S. et al. (1988) Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. Proc. Natl. Acad. Sci. U. S. A. 85, 8459-8463
46. Doi, T. et al. (1990) Role of the intradiscal domain in rhodopsin assembly and function. Proc. Natl. Acad. Sci. U. S. A. 87, 4991-4995
47. Hwa, J. et al. (2001) Structure and function in rhodopsin: mass spectrometric identification of the abnormal intradiscal disulfide bond in misfolded retinitis pigmentosa mutants. Proc. Natl. Acad. Sci. U. S. A. 98, 4872-4876
48. Hwa, J. et al. (1999) Structure and function in rhodopsin: further elucidation of the role of the intradiscal cysteines, Cys-110, -185, and -187, in rhodopsin folding and function. Proc. Natl. Acad. Sci. U. S. A. 96, 1932-1935
49. Davidson, F.F. et al. (1994) Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light activated metarhodopsin II state. Proc. Natl. Acad. Sci. U. S. A. 91, 4029-4033
50. Hubbell, W.L. et al. (2003) Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Adv. Protein Chem. 63, 243-290
51. Dixon, R.A. et al. (1987) Structural features required for ligand binding to the beta-adrenergic receptor. EMBO J. 6, 3269-3275
52. Pederson, S.E. and Ross, E.M. (1985) Functional activation of beta-adrenergic receptors by thiols in the presence or absence of agonists. J. Biol. Chem. 260, 14150-14157
53. Noda, K.N. et al. (1994) The high affinity state of the β2-adrenergic receptor requires unique interaction between conserved and nonconserved extracellular loop cysteines. J. Biol. Chem. 269, 6743-6752
54. Zeng, F.Y. et al. (1999) Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is necessary for proper receptor cell surface localization, but not for G protein coupling. J. Neurochem. 72, 2404-2414
55. 2 angiotensin receptor from cysteine-disulfide bond exchange. FEBS Lett. 484, 133-138
56. Zhang, R. et al. (1996) Requirement of cysteine residues in exons 1-6 of the extracellular domain of the luteinizing hormone receptor for gonadotropin binding. J. Biol. Chem. 271, 5755-5760
57. d'Addio, M. et al. (2000) Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum. Mol. Genet. 9, 3011-3018
58. Knudsen, S.M. et al. (1997) A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation. FEBS Lett. 412, 141-143
59. Vilardaga, J.P. et al. (1997) Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function. Eur. J. Biochem. 246, 173-180
60. Kenakin, T. (2002) Drug efficacy at G protein coupled receptors. Annu. Rev. Pharmacol. Toxicol. 42, 349-379